Tissutal immune profile and pathological complete response in triple negative breast cancer

被引：0
|
作者：
Botticelli, Andrea [1 ]
Cerbelli, Bruna [1 ]
Scagnoli, Simone [1 ]
Amabile, Maria Ida [1 ]
De Luca, Alessandro [1 ]
Fortunato, Lucio [2 ]
Costarelli, Leopoldo [2 ]
Nuti, Marianna [1 ]
D'Amati, Giulia [1 ]
Marchetti, Paolo [1 ]
机构：
[1] Sapienza Univ Rome, Rome, Italy
[2] San Giovanni Addolorata Hosp, Rome, Italy
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P114
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response
    Loibl, S.
    Schneeweiss, A.
    Huober, J.
    Braun, M.
    Rey, J.
    Blohmer, J. U.
    Furlanetto, J.
    Zahm, D. M.
    Hanusch, C.
    Thomalla, J.
    Jackisch, C.
    Staib, P.
    Link, T.
    Rhiem, K.
    Solbach, C.
    Fasching, P. A.
    Nekljudova, V.
    Denkert, C.
    Untch, M.
    ANNALS OF ONCOLOGY, 2022, 33 (11) : 1149 - 1158
  • [22] Predictive value of neutrophil-to-lymphocyte ratio on pathological complete response in triple negative breast cancer.
    Enriquez, Daniel
    Ku, Gabriel Antonio De la Cruz
    Fernandez, Margiory
    Eyzaguirre, Eduardo
    Luque, Renato
    Paitan, David
    Lujan, Maria
    Saavedra, Antonella
    Valcarcel, Bryan
    Morante, Zaida
    Fuentes, Hugo Alejandro
    Neciosup, Silvia P.
    Gomez, Henry Leonidas
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [23] Luminal androgen receptor role and pathological complete response rate to neoadjuvant chemotherapy in triple negative breast cancer
    Chica-Parrado, M. R.
    Santonja, A.
    Lluch-Hernandez, A.
    Albanell, J.
    Sanchez-Munoz, A.
    Chacon, I.
    Calvo, L.
    Sanchez-Rovira, P.
    De la Haba, J.
    Vicioso, L.
    Martin, M.
    Plazaola, A.
    Prat, A.
    Ribelles, N.
    Sanchez-Arago, M.
    Jerez, J. M.
    Escudero, M. J.
    Caballero, R.
    Carrasco, E.
    Alba Conejo, E.
    ANNALS OF ONCOLOGY, 2016, 27
  • [24] A microRNA signature associated with pathological complete response to a novel neoadjuvant therapy regimen in triple negative breast cancer
    Garcia Vazquez, Raul
    Lopez Camarillo, Cesar
    Marchat Marchau, Laurence
    Ruiz Garcia, Erika
    Alvarado Miranda, Alberto
    Maldonado Martinez, Hector
    Campos Parra, Alma
    Astudillo De la Vega, Horacio
    Gonzalez Barrios, Antonio
    Rodriguez Cuevas, Sergio
    CANCER RESEARCH, 2018, 78 (04)
  • [25] Prediction of pathological complete response to neoadjuvant chemotherapy in early triple negative breast cancer patients by serial breast ultrasound examination
    Rapoport, Bernardo
    Smit, Teresa
    Heyman, Liezl
    Moosa, Farhana
    Benn, Carol Ann
    CANCER RESEARCH, 2021, 81 (04)
  • [26] Immune characterization of inflammatory breast cancer and correlation to pathological complete response
    Reddy, S. M.
    Wargo, J. A.
    Reuben, A.
    Reuben, J.
    Woodward, W.
    Ueno, N.
    Mittendorf, E. A.
    Krishnamurthy, S.
    CANCER RESEARCH, 2017, 77
  • [27] Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer
    Marhold, Maximilian
    Udovica, Simon
    Halstead, Anna
    Hirdler, Mona
    Ferner, Muna
    Wimmer, Kerstin
    Bago-Horvath, Zsuzsanna
    Exner, Ruth
    Fitzal, Florian
    Strasser-Weippl, Kathrin
    Robinson, Tim
    Bartsch, Rupert
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [28] A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence
    Marcia V. Fournier
    Edward C. Goodwin
    Joan Chen
    John C. Obenauer
    Susan H. Tannenbaum
    Adam M. Brufsky
    Scientific Reports, 9
  • [29] Pathological Complete Response to Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: An Updated Meta-Analysis
    Rizzo, Alessandro
    Cusmai, Antonio
    Massafra, Raffaella
    Bove, Samantha
    Comes, Maria Colomba
    Fanizzi, Annarita
    Rinaldi, Lucia
    Acquafredda, Silvana
    Gadaleta-Caldarola, Gennaro
    Oreste, Donato
    Zito, Alfredo
    Giotta, Francesco
    Lorusso, Vito
    Palmiotti, Gennaro
    CELLS, 2022, 11 (12)
  • [30] Predictive biomarkers for pathological complete response in early-stage triple negative breast cancer following neoadjuvant chemotherapy
    Polho, Gabriel Berlingieri
    Testa, Laura
    Barroso-Sousa, Romualdo
    Bonadio, Renata Colombo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345